Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8K Sell
63
-47
-43% -$6.57K 0.01% 1599
2025
Q4
$18K Sell
110
-10
-8% -$1.57K 0.01% 1329
2025
Q3
$16K Buy
120
+50
+71% +$6.07K 0.01% 1374
2025
Q2
$9K Buy
70
+13
+23% +$1.65K 0.01% 1648
2025
Q1
$7K Sell
57
-68
-54% -$10.5K ﹤0.01% 1675
2024
Q4
$18K Buy
125
+27
+28% +$3.87K 0.01% 1253
2024
Q3
$15K Buy
98
+26
+36% +$3.73K 0.01% 1330
2024
Q2
$9K Sell
72
-295
-80% -$46.2K 0.01% 1631
2024
Q1
$68K Sell
367
-5
-1% -$952 0.04% 754
2023
Q4
$67K Sell
372
-318
-46% -$49.5K 0.05% 723
2023
Q3
$110K Sell
690
-145
-17% -$23.7K 0.08% 360
2023
Q2
$118K Buy
835
+139
+20% +$22.3K 0.09% 344
2023
Q1
$117K Buy
696
+16
+2% +$2.85K 0.1% 296
2022
Q4
$115K Buy
680
+47
+7% +$8.53K 0.09% 328
2022
Q3
$118K Buy
633
+53
+9% +$11.2K 0.1% 273
2022
Q2
$94K Buy
580
+96
+20% +$15.2K 0.07% 460
2022
Q1
$91K Buy
484
+179
+59% +$34K 0.06% 568
2021
Q4
$81K Buy
+305
New +$82.2K 0.11% 265

Other funds holding RGEN

Covestor's RGEN Position: Q1 2026 in Review

Covestor reduced its Repligen (RGEN) stake by 43% in Q1 2026, selling an estimated $6.57K and leaving 63 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #1599.

Covestor first reported a position in RGEN in Q4 2021 and has held it in 18 quarters since. The position peaked at $118K in Q2 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Covestor held 63 shares of Repligen worth $8K as of Q1 2026.
  • Covestor sold 47 Repligen shares in Q1 2026, an estimated $6.57K.
  • Repligen made up 0.01% of Covestor's portfolio in Q1 2026, its #1599 holding.
  • Covestor first reported a position in Repligen in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Repligen position peaked at $118K in Q2 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.